Share  |  Print  |  Facebook  |  Twitter  |  

Urge Your Congressperson: Cosponsor the PSA Screening for HIM Act Today

Please fill out the form below to tell your Member of Congress to cosponsor the PSA Screening for HIM Act!


  • Your Representative

Your Contact Information

*Required fields


If you take action and have not already registered, you will receive periodic updates and communications from ZERO - The End of Prostate Cancer.

PSA Screening for HIM Act Cosponsor Request

Dear [Congressman/Congresswoman],

As your constituent and someone who has been impacted by prostate cancer, I'm writing to request your cosponsorship of HR 5200, the Prostate-specific Antigen Screening for High-Risk Insured Men Act (PSA Screening for HIM Act). In 2019, more than 174,650 men across the U.S. will be diagnosed with prostate cancer, and over 31,620 more will die of the disease. Among American males, prostate cancer is the most-diagnosed cancer and is the third highest cancer-related cause of death.

The PSA Screening for HIM Act would ensure that men who are at the highest risk for developing aggressive disease, African-American men and those with a family history, are able to access prostate cancer screenings without any cost-sharing barriers.

This legislation would require that private insurers treat two categories of high-risk men -- African Americans and those with a family history of prostate cancer -- as if the United States Preventive Services Task Force (USPSTF) has recommended an "A" rating for prostate specific antigen (PSA) screening for prostate cancer, meaning that under the Affordable Care Act (ACA) insurance coverage without copays for the test would be guaranteed.

In 2018, after years of arguing against the screening, the Task Force upgraded their recommendation in 2018 to a "C", meaning men should have a conversation with their doctor about the harms and benefits of the screening. In that recommendation that USPSTF reported their concern about the lack of data for high-risk men, and in their 2018 annual report to Congress referred to "Screening for Prostate Cancer, Especially Among African American Men and Men With a Family History" as a high-priority recent research gap.

Unfortunately, such studies could take decades to complete. Meanwhile, after two decades of falling death rates, we are experiencing a rise in prostate cancer deaths since the USPSTF's discouragement of PSA screening in 2012. Rather than allow thousands of men to go unscreened, Congress should step in with a common sense approach to fill this glaring data gap.

I hope you will join Congressmen Rush and Bucshon as a cosponsor of the PSA Screening for HIM Act, so that we can ensure the men at the highest risk for prostate cancer are able to get screened without any access barriers.

Thank you for your consideration of this important legislation,
[Your Name]
[Your Address]
[City, State ZIP]
[Your Email]